Molecule Details
InChIKeyYMHQYWPVQDRYSQ-LMPQEXDPSA-N
Compound Nametert-butyl N-[(1S)-1-[(2S,4R)-2-[[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinyl-cyclopropyl]carbamoyl]-4-[(7-methoxy-2-phenyl-4-quinolyl)oxy]pyrrolidine-1-carbonyl]-2,2-dimethyl-propyl]carbamate
Canonical SMILESC=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3ccccc3)nc3cc(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Cross-Family
Avg pChEMBL8.17
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
F5B4I0 Hepacivirus hominis Pathogen PF01001 9.0 IC50 ChEMBL
A3EZI9 NS3 Hepacivirus hominis Pathogen PF07652 PF22027 PF02907 7.8 IC50 ChEMBL;BindingDB
D2K2A8 NS4A Hepacivirus hominis Pathogen PF01006 7.8 IC50 ChEMBL